KIF3C has been reported to enhance cancer progress by regulating the phosphatidylinositol 3-kinase (PI3K)/AKT pathway and transforming growth factor beta (TGF-β) pathway [36, 47, 48]. This evidence concerns the gene TGFB1 and cancer.